Direct factory supply from Shaanxi ShineHerb Biotech Co., Ltd. Fully certified with HPLC/UV release specifications, international pharmacopoeial standards, and complete batch-traceable analysis.
Ultra-High Viability Lyophilized Potency
Gastric Acid Survival Rate (pH 2.5, 2h)
Global Markets Supplying Certified Probiotics
Standard Cleanrooms & Cold-Chain Logistical Hubs
An authoritative industrial assessment of Lactobacillus gasseri as a flagship symbiotic organism. Unmatched metabolic modulation, mucosal adherence kinetics, and superior stability for demanding clinical formulations.
Lactobacillus gasseri represents a critical Gram-positive, rod-shaped, non-spore-forming lactic acid bacterium belonging to the core Lactobacillus acidophilus complex. Isolated natively from healthy human breast milk and vaginal tracts, our selected commercial strains exhibit authenticated 16S rRNA genetic sequencing, comprehensive whole-genome sequencing (WGS), and phenotypic stability across industrial fermentation generations.
What sets L. gasseri apart in competitive colonization is its biological synthesis of class II bacteriocins, notably Gassericin A and Gassericin T. These heat-stable, ribosomally synthesized peptide complexes systematically destabilize cytoplasmic membranes of pathogenic invaders including Staphylococcus aureus, Listeria monocytogenes, and recurrent vaginosis culprits like Gardnerella vaginalis without provoking inflammatory cascade reactions.
Extensive global clinical trials corroborate that proprietary Lactobacillus gasseri strains directly impact the host's metabolome. By expressing bile salt hydrolase (BSH) activity, down-regulating intestinal fatty acid absorption, and stimulating short-chain fatty acid (SCFA) cascades, it induces peroxisome proliferator-activated receptor alpha (PPAR-α) signaling, dramatically lowering abdominal visceral and subcutaneous adipocyte enlargement.
As consumer demand shifts from generic multi-strain cocktails toward clinically evidenced, target-specific probiotics, Lactobacillus gasseri is positioned as one of the fastest-growing functional strains across Europe, North America, and the Asia-Pacific region.
With global healthcare systems wrestling with metabolic syndrome and non-alcoholic fatty liver diseases (NAFLD), pharmaceutical and functional food developers are heavily sourcing clinical L. gasseri isolates. Market valuation for targeted metabolic-support probiotics is projected to surpass $1.4 Billion by 2030, clocking a compound annual growth rate (CAGR) of 8.9%. Importers require uncompromised living cell count assurances upon delivery to sustain rigorous shelf-life claim guarantees.
Historically, feminine wellness was constrained to external antiseptics that continuously disrupt delicate physiological flora. Today, the feminine micro-ecological sector prioritizes oral and suppository-grade L. gasseri due to its unique endogenous residency and rapid H2O2 production capability. The demand for OEM finished blends combining L. gasseri with Lactobacillus rhamnosus and D-Mannose has tripled across EU and North American contract formulators.
Shaanxi ShineHerb Biotech Co., Ltd., based in the high-tech biomanufacturing corridor of Xi'an, utilizes next-generation automated multi-ton anaerobic fermenters paired with proprietary cryogenic recovery. By capitalizing on integrated raw material supply lines and pharmacopoeia-referenced testing laboratories, China now delivers pharmaceutical-grade L. gasseri powders at high viability thresholds, challenging legacy Western monopoly pricing while elevating batch repeatability.
Formulating with sensitive living biologicals necessitates deep matrix compatibility understanding. Here is how leading global manufacturers incorporate our bulk Lactobacillus gasseri powders across diverse delivery formats.
Formulated using enteric DRCaps or delayed-release HPMC shells, combined with low water activity (aw < 0.15) prebiotics such as Inulin or Fructooligosaccharides (FOS). Provides optimum gastric bypass for metabolic body-sculpting programs.
Ultra-fine milled lyophilized powders compatible with direct compression matrices. Maintains direct vaginal mucosa adherence, generating protective lactic acid barriers to stabilize physiological vaginal pH between 3.8 and 4.4.
Direct Vat Inoculation (DVI) strains for ambient and cold-chain yogurt, kefir, and plant-based oat milks. Demonstrates high proteolytic capability, releasing bio-active peptides that assist in sustained blood pressure and satiety regulation.
Heat-inactivated lysates (postbiotics) and tyndallized L. gasseri for skin microbiome preservation. Proven to enhance ceramidase expression, reduce trans-epidermal water loss (TEWL), and soothe acne flare-ups triggered by C. acnes overpopulation.
Every batch of Lactobacillus gasseri produced at our Xi'an processing facility adheres to strict microbiological, physical, and molecular quality verification monographs.
| Analytical Parameter | Commercial Grade Standard | Pharma / Clinical Grade Standard | Verification Test Methodology |
|---|---|---|---|
| Potency (Viable Count) | ≥ 1.0 × 10¹¹ CFU/g (100B) | ≥ 3.0 × 10¹¹ to 5.0 × 10¹¹ CFU/g | ISO 19344 / IDF 232 (Flow Cytometry) / Agar Plate |
| Identity / Strain Purity | Conforms to L. gasseri | 100% Homology to Master Stock | 16S rDNA PCR & WGS Metagenomic Profiling |
| Physical Morphology | Off-white to light yellow powder | Uniform free-flowing micronized powder | Organoleptic / Microscopy Inspection |
| Moisture Content (Karl Fischer) | ≤ 5.0% | ≤ 3.0% (Enhanced Nitrogen Sparged) | USP <921> Method I |
| Water Activity (aw) | ≤ 0.20 | ≤ 0.12 | Rotronic Chilled Mirror Dewpoint Hygrometry |
| Heavy Metals (Pb, As, Cd, Hg) | Pb ≤ 0.5ppm, As ≤ 0.5ppm | Total Heavy Metals < 2.0 ppm | ICP-MS Inductively Coupled Plasma Mass Spec |
| Pathogenic Microorganisms | Absent in 25g (Salmonella, E. coli) | USP <2021> / <2022> Compliant | BAM Chapter 4, 5 & Selective Enrichment |
| Residual Solvents & Allergens | Non-detectable | Dairy-free, Soy-free, Non-GMO Validated | Gas Chromatography Headspace (GC-HS) / ELISA |
Preserving viability in high-density lactic acid cultures demands extreme thermodynamic and osmotic control. Our 4-stage proprietary biomanufacturing architecture safeguards strain efficacy.
Working cell banks thawed under computer-controlled inert argon blankets. Multi-stage automated bio-reactors balance pH (via ammonia water titration), nitrogen source feeding, and precise glucose feed rates to harvest cells at peak stationary viability.
Super-speed continuous disk-stack centrifugation separated at low temperatures (4°C–8°C) removes spent fermentation broth without causing shear damage to bacterial flagella, cell membranes, or surface S-layer functional proteins.
Active cell slurry is embedded in an all-natural protective matrix comprising trehalose, sodium ascorbate, and pharmaceutical pullulan. This shields the sensitive peptidoglycan wall from ice crystal piercing during shock freezing at -55°C.
Sublimation lyophilized inside Class 100,000 cleanrooms under deep vacuum conditions. The resulting probiotic dry sponge is gently shattered in nitrogen-gas-flushed jet mills to produce uniform 80-100 mesh powders with moisture content under 3%.
Shaanxi ShineHerb Biotech Co., Ltd. solves procurement bottlenecks for multinational brand owners, contract manufacturing organizations (CMOs), and pharmaceutical packagers.
We standardize L. gasseri from concentrated pure actives (500B CFU/g) down to client-tailored concentrations (10B, 50B, or 100B CFU/g) using certified maltodextrin, microcrystalline cellulose (MCC), corn starch, or prebiotic soluble fibers to match your capsule size and volumetric filling machines.
Eliminate launch risk with comprehensive accelerated (40°C/75% RH) and zone IV long-term (25°C/60% RH) stability dossiers. Our application labs provide survival curve equations, shelf-life models, and overage recommendation algorithms for any container-closure system.
Living strains require strict thermal control. We ship export consignments in thermal vacuum insulated packaging (VIP) equipped with multi-channel USB temperature data loggers, utilizing expedited air cargo lanes to ensure port-to-port temperature control within -18°C to +4°C.
Direct answers to core questions posed by international technical procurement teams, formulation specialists, and quality auditors.
When stored in original unopened, nitrogen-purged aluminum vacuum bags at -18°C (deep-frozen), our Lactobacillus gasseri maintains authenticated viable cell counts for 24 months. For refrigerated distribution (4°C to 8°C), stability is validated for 12 months with minimal decline, typically requiring only a 15–20% standard formulation overage depending on the packaging moisture barrier.
In accordance with European Food Safety Authority (EFSA) guidance on antimicrobial resistance in probiotic bacteria, every commercial master seed lot is sequenced for both intrinsic and acquired transmissible resistance genes. Our L. gasseri lacks transferable plasmids for vancomycin, ampicillin, erythromycin, or tetracycline resistance, making it safe for long-term human consumption.
We supply standard carriers including organic potato maltodextrin, tapioca maltodextrin, resistant dextrin, microcrystalline cellulose (MCC 102/112), and anhydrous glucose. For certified organic or clean-label lines, we provide pre-blends utilizing organic acacia gum or certified prebiotic Agave inulin, with verified ultra-low water activity to eliminate strain degradation.
Every export lot is shipped with a comprehensive batch Certificate of Analysis (COA) specifying Colony Forming Units (CFU/g), moisture %, water activity (aw), heavy metal contaminants, and comprehensive pathogen panels (USP <2021>/<2022>). Additionally, ISO 9001, HACCP, HALAL, KOSHER, Allergen-free, and Non-GMO declarations are available for swift customs clearance.
Yes. We specialize in compounding Lactobacillus gasseri with synergistic probiotic species (such as Bifidobacterium lactis, Lactobacillus acidophilus, Lactobacillus plantarum) and functional actives like Plant Extracts, Niacinamide, Vitamin K2 MK-7, or Digestive Enzymes in our GMP blending cleanrooms to save formulators labor and cross-contamination risks.
Standard evaluation sample kits (50g to 100g) are available to qualified business entities accompanied by a complete technical dossier and test method SOP. Commercial production MOQ starts at 1 kg for high-potency concentrates (100B–500B CFU/g), packaged in multilayer sealed aluminum pouches with specialized dry desiccant strips.
Expand your production lines with our complementary catalog of functional vitamins, cosmetic raw materials, amino acid chelates, and natural extract concentrates.